We are live on ! Find out more
CCCC icon

C4 Therapeutics
CCCC

113 hedge funds and large institutions have $1.54B invested in C4 Therapeutics in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 53 increasing their positions, 20 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

165% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 20

58% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 12

28% more capital invested

Capital invested by funds: $1.21B → $1.54B (+$334M)

6% more funds holding

Funds holding: 107 → 113 (+6)

2.76% less ownership

Funds ownership: 73.95% → 71.19% (-2.8%)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
113
Holders Change
+6
Holders Change %
+5.61%
% of All Funds
1.98%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
19
Increased
53
Reduced
20
Closed
12
Calls
$4.63M
Puts
–
Net Calls
+$4.63M
Net Calls Change
+$2.71M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$22.8M
2
BlackRock
BlackRock
New York
+$22.5M
3
DCM
Driehaus Capital Management
Illinois
+$18.6M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$17.7M
5
RI
RTW Investments
New York
+$14.8M

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$13.4M
2
MS
Maven Securities
Jersey
-$8.96M
3
LCM
Laurion Capital Management
New York
-$6.55M
4
MS
Mizuho Securities
Japan
-$6.41M
5
PCM
Pinz Capital Management
New York
-$6.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
GGHC
51
Gilder Gagnon Howe & Co
New York
$1.76M +$1.69M +39,506 New
RhumbLine Advisers
52
RhumbLine Advisers
Massachusetts
$1.71M +$155K +3,630 +11%
SC
53
Shay Capital
New York
$1.68M +$1.61M +37,500 New
CSS
54
Cubist Systematic Strategies
Connecticut
$1.67M +$1.18M +27,567 +283%
Ohio Public Employees Retirement System (OPERS)
55
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.66M – – –
California State Teachers Retirement System (CalSTRS)
56
California State Teachers Retirement System (CalSTRS)
California
$1.33M -$760K -17,757 -37%
HS
57
HighVista Strategies
Massachusetts
$1.31M +$326K +7,612 +35%
Wells Fargo
58
Wells Fargo
California
$1.27M +$1.21M +28,341 +80,974%
PPA
59
Parametric Portfolio Associates
Washington
$1.2M +$55.5K +1,297 +5%
CAPTRUST Financial Advisors
60
CAPTRUST Financial Advisors
North Carolina
$1.18M – – –
Ensign Peak Advisors
61
Ensign Peak Advisors
Utah
$1.15M -$608K -14,207 -36%
New York State Common Retirement Fund
62
New York State Common Retirement Fund
New York
$1.11M -$198K -4,626 -16%
Deutsche Bank
63
Deutsche Bank
Germany
$1.08M +$99.7K +2,327 +11%
Swiss National Bank
64
Swiss National Bank
Switzerland
$1.06M – – –
Prudential Financial
65
Prudential Financial
New Jersey
$1.04M +$30K +700 +3%
Bank of America
66
Bank of America
North Carolina
$963K -$546K -12,754 -37%
AIG
67
American International Group
New York
$945K +$79.2K +1,849 +10%
Two Sigma Investments
68
Two Sigma Investments
New York
$942K +$433K +10,100 +92%
ACP
69
Acuta Capital Partners
California
$938K +$899K +21,000 New
Vontobel Holding
70
Vontobel Holding
Switzerland
$894K – – –
PVI
71
Pura Vida Investments
New York
$894K +$856K +20,000 New
Manulife (Manufacturers Life Insurance)
72
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$866K +$13.2K +308 +2%
DACS
73
Dymon Asia Capital (Singapore)
Singapore
$737K +$341K +7,952 +93%
VOYA Investment Management
74
VOYA Investment Management
Georgia
$664K +$55.8K +1,304 +10%
DWA
75
Douglass Winthrop Advisors
New York
$626K – – –
1 2
3
4 5

CCCC Hedge Fund Activity: Q3 2021 in Review

113 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in C4 Therapeutics (CCCC) for Q3 2021, worth a combined $1.54B — up 28% from $1.21B a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new CCCC positions and 12 closed out — a net gain of 7 holders — while 53 added to existing stakes and 20 trimmed.

The largest buyer was Vanguard Group, adding an estimated $22.8M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $13.4M sold.

  • 113 institutional investors held C4 Therapeutics (CCCC) as of Q3 2021, up from 107 in Q2 2021.
  • Funds reported $1.54B of C4 Therapeutics stock for Q3 2021, up 28% quarter-over-quarter.
  • 19 funds opened new C4 Therapeutics positions in Q3 2021 and 12 closed out, a net change of +7 holders.
  • The largest C4 Therapeutics buyer in Q3 2021 was Vanguard Group, an estimated $22.8M added.
  • The largest C4 Therapeutics seller in Q3 2021 was Cormorant Asset Management, an estimated $13.4M sold.

Based on aggregated 13F filings for Q3 2021.